Reporting
We provide companies of all sizes with financial reporting services for stock-based compensation.
Valuation
Get fair value measurement and modeling for all sorts of equity-based awards and securities, whether business as usual or special circumstances.
Complex Securities Valuation
HR Advisory
Our HR advisory services provide the insight you need to improve program design, grant more equity, and tell a cleaner story in your proxy and financial statements.
CEO Pay Ratio
Resources
Dive into our library of publications on a wide range of stock-based compensation topics.
About Us
We’re dedicated to bringing insight, control, and expanded capability to your compensation strategy.
Conference June 5, 2025 Posted on: 5/26/2025
Join Equity Methods at the National Association of Stock Plan Professionals (NASPP) New England Summit!
Opening General Session: Equity Compensation in 2025: Adapting to a New Era with Nate O’Connor
9:20am – 10:20am EDT
Three years ago, in the wake of the COVID pandemic, we shared our thoughts and predictions on the evolving landscape of equity compensation with the New England NASPP Summit. Little did we know how much could change in such a short time. This year, with the arrival of a new presidential administration, it’s time to reassess the equity compensation landscape. Market volatility and other macroeconomic and social factors continue to influence equity incentives. Technologies such as artificial intelligence and digital assets are advancing rapidly, though their implications for our beloved industry aren’t always clear.
In this dynamic and sometimes chaotic environment, compensation professionals have been tasked with construction of new disclosures like pay vs. performance and are now forced to prepare for disaggregation of the income statement, which will dramatically impact the way compensation is presented in the company’s financials in years to come. In this rapidly changing landscape, staying informed about court cases, SEC comment letters, rulemaking and enforcement actions is even more crucial than before.
Joining Nate for this keynote address are Zachary Doyle (Vertex Pharmaceuticals) and Wells Miller (Akin Gump)
We hope to see you there!